doi: 10.1016/S0076-6879(04)92020-4.
Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection
Affiliations
- PMID: 15644191
- DOI: 10.1016/S0076-6879(04)92020-4
Item in Clipboard
Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection
Methods Enzymol.
2005.
Abstract
Extensive use of RNA interference in mammals has been hindered by the inability to effectively deliver small interfering RNAs (siRNAs) or DNA-based constructs designed to express siRNAs. In this chapter, we describe the high-pressure or hydrodynamic intravascular injection technique used to deliver these nucleic acids to mice and nonhuman primates. Emphasis is placed on the use of this technique for delivery to the liver.
Similar articles
-
Hydrodynamic delivery protocols.Methods Mol Biol. 2010;623:189-95. doi: 10.1007/978-1-60761-588-0_12. Methods Mol Biol. 2010. PMID: 20217552
-
Systemic siRNA delivery via hydrodynamic intravascular injection.Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):115-23. doi: 10.1016/j.addr.2007.03.002. Epub 2007 Mar 15. Adv Drug Deliv Rev. 2007. PMID: 17442446 Review.
-
The mechanism of naked DNA uptake and expression.Adv Genet. 2005;54:3-20. doi: 10.1016/S0065-2660(05)54001-X. Adv Genet. 2005. PMID: 16096005 Review.
-
Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAs.Methods Mol Biol. 2007;361:217-26. doi: 10.1385/1-59745-208-4:217. Methods Mol Biol. 2007. PMID: 17172714
-
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.Toxicol Appl Pharmacol. 2009 Apr 1;236(1):97-108. doi: 10.1016/j.taap.2009.01.014. Epub 2009 Jan 29. Toxicol Appl Pharmacol. 2009. PMID: 19371615
Cited by
-
Target selectivity in mRNA silencing.Gene Ther. 2006 Mar;13(6):509-16. doi: 10.1038/sj.gt.3302726. Gene Ther. 2006. PMID: 16520821 Free PMC article. Review.
-
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus.Sci Rep. 2015 Jun 2;5:10833. doi: 10.1038/srep10833. Sci Rep. 2015. PMID: 26035283 Free PMC article.
-
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside.Pharmaceuticals (Basel). 2020 Oct 7;13(10):294. doi: 10.3390/ph13100294. Pharmaceuticals (Basel). 2020. PMID: 33036435 Free PMC article. Review.
-
RNA interference: from gene silencing to gene-specific therapeutics.Pharmacol Ther. 2005 Aug;107(2):222-39. doi: 10.1016/j.pharmthera.2005.03.004. Pharmacol Ther. 2005. PMID: 15908010 Free PMC article. Review.
-
Gene therapy for arthritis--where do we stand?Arthritis Res Ther. 2005;7(6):227-9. doi: 10.1186/ar1823. Epub 2005 Sep 14. Arthritis Res Ther. 2005. PMID: 16277696 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
